Found 7 matching trials
Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
N/AThis expanded access use program will provide a botanical drug of T89 for t...
Status
No Longer Available
Location
MultiCare Health System
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
PHASE3This phase III study is designed as a double blind, randomized, multi-natio...
Location
Cardiology and Medicine Clinic
Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
PHASE2Acute mountain sickness (AMS) is one of three syndromes of altitude illness...
Location
Hypoxia Research Lab, UCSF Parnassus Campus, S-256
Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
PHASE3The specific aim of this double blind, randomized phase III trial is to eva...
Location
Hypoxia Research Lab, UCSF Parnassus Campus, S-256
A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes
PHASE1Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enz...
Location
Comprehensive Clinical Development NW Inc.
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
PHASE3This is a multi-center, double-blind, randomized, placebo-controlled, paral...
Location
Southwest Florida Research LLC
Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
PHASE2The purpose of this study is to determine the anti-angina effect and dose r...
Location
Paradigm Clinical, Inc.